United Therapeutics | Passivo Circulante



Current Liabilities Alterar Data
Amarin USD 201.55M 28.99M 2024-09
Ardelyx USD 77.83M 7.33M 2024-12
Baxter International USD 6.51B 311M 2024-12
Bayer EUR 28.95B 3.9B 2024-12
Biogen USD 5.3B 231.4M 2025-03
BioMarin Pharmaceutical USD 628.21M 21.22M 2025-03
Gilead Sciences USD 12B 279M 2024-12
GlaxoSmithKline GBP 20.83B 866M 2025-03
Halozyme Therapeutics USD 150.38M 11.28M 2025-03
Insmed USD 297.53M 38.34M 2024-12
Ionis Pharmaceuticals USD 250.29M 59.02M 2025-03
J&J USD 56.9B 6.58B 2025-03
Moderna USD 1.6B 602M 2025-03
Pfizer USD 36.45B 6.54B 2025-03
PTC Therapeutics USD 595.39M 14.41M 2025-03
Regeneron Pharmaceuticals USD 3.57B 2.13B 2025-03
Sarepta Therapeutics USD 605.59M 126.1M 2025-03
Teva Pharmaceutical Industries USD 11.16B 1.64B 2025-03
United Therapeutics USD 721.5M 16.6M 2025-03
Vertex Pharmaceuticals USD 3.56B 408.5M 2024-12



United Therapeutics Passivo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - May 2025.